Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic … – Business Wire (press release)
|
Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic …
Business Wire (press release) “Allogenic cell therapies using CAR–T open a major field of innovation in the treatment of cancer,” stated Patrick Therasse, Oncology Research and Development Director at Servier. “However, each of the steps in their complex manufacturing process … |
